GlassScriptPhysician profile
Jennifer E Lane
NPI 1326270570
$1,839.01
in general payments reported to CMS, 2019-2025
15 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.97 · 2022: $105 · 2023: $813 · 2024: $601 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $663.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $298.84 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $296.52 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.73 | 2022-2023 | |
| Exact Sciences Corporation | $80.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $78.52 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.12 | 2023-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $50.75 | 2023-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $48.64 | 2021 | |
| Amgen INC. | $45.85 | 2024-2025 | Evenity, Prolia |
| E.R. Squibb & Sons, L.L.C. | $34.30 | 2024-2025 | Camzyos, Eliquis |
| Phathom Pharmaceuticals, INC. | $25.67 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $23.72 | 2025 | Auvelity |
| Inogen, INC. | $16.88 | 2023 | Inogen At Home Stationary Concentrator |
| Intra-Sana Laboratories | $13.32 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.